Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 17.95
+0.22 (1.24%)
Apr 1, 2026, 3:04 PM CST
Jafron Biomedical Revenue
Jafron Biomedical had revenue of 421.61M CNY in the quarter ending September 30, 2025, a decrease of -39.78%. This brings the company's revenue in the last twelve months to 2.04B, down -22.58% year-over-year. In the year 2024, Jafron Biomedical had annual revenue of 2.68B with 39.27% growth.
Revenue (ttm)
2.04B
Revenue Growth
-22.58%
P/S Ratio
6.74
Revenue / Employee
728.51K
Employees
2,500
Market Cap
13.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.68B | 754.97M | 39.27% |
| Dec 31, 2023 | 1.92B | -569.09M | -22.84% |
| Jan 1, 2023 | 2.49B | -184.02M | -6.88% |
| Jan 1, 2022 | 2.68B | 724.67M | 37.15% |
| Dec 31, 2020 | 1.95B | 518.96M | 36.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Autobio Diagnostics | 4.22B |
| Shandong Weigao Blood Purification Products | 3.77B |
| Cofoe Medical Technology | 3.39B |
| Double Medical Technology | 2.48B |
| SonoScape Medical | 2.07B |
| MeHow Innovative | 1.63B |
| Shandong Weigao Orthopaedic Device | 1.52B |
| Shanghai MicroPort Endovascular MedTech | 1.35B |